CohBar Inc
Change company Symbol lookup
Select an option...
CWBR CohBar Inc
PRA ProAssurance Corp
CAJFF Canon Inc
INSG Inseego Corp
LVRLF CordovaCann Corp
SRNE Sorrento Therapeutics Inc
JWN Nordstrom Inc
BKKXF Bangkok Expressway and Metro PCL
KEX Kirby Corp
CGEI CGE Energy Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

CohBar, Inc. (CohBar), is a clinical stage biotechnology company. The Company is focused on the research and development of mitochondria-based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The Company has discovered more than 100 mitochondrial-derived peptides and is focused on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases, including nonalcoholic steatohepatitis (NASH), obesity, cancer, fibrotic diseases including idiopathic pulmonary fibrosis (IPF), type 2 diabetes (T2D), cardiovascular and neurodegenerative diseases. The Company’s lead compound, CB4211, is in the phase 1b stage of a phase 1a/1b clinical trial for NASH and obesity. In addition, CohBar has four preclinical programs that include MBT5 Analogs (CXCR4 Antagonists) for Cancer and Other Disease Indicatio, MBT2 Analogs for Fibrotic Diseases, MBT3 Analog for Cancer Immunotherapy and CB5064 Analogs for Type 2 Diabetes.

Price
Delayed
$1.26
Day's Change
-0.005 (-0.40%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.29
Day's Low
1.23
Volume
(Average)

Today's volume of 151,358 shares is on pace to be in-line with CWBR's 10-day average volume of 593,489 shares.

151,358
  • Prev Close
    1.26
  • Today's Open
    1.25
  • Day's Range
    1.23-1.29
  • Avg Vol (10-day)
    593.5K
  • Last (time)
    10:58a ET 11/25/20
  • Last (size)
    500
  • 52-Wk Range
    0.85 - 4.25
    LowHigh
  • (05/06/20 - 08/27/20)
    47.65%
  • 112.5%
  • Market Cap
    72.5M
  • Shares Outstanding
    58.0M
  • -0.34
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.5
  • 12.28
  • (% of float 11/15/20)
    3.18

Latest News

November 19, 2020
9:00 am ET
Globe Newswire
November 16, 2020
4:01 pm ET
Globe Newswire
3:15 pm ET
Accesswire
November 02, 2020
9:00 am ET
Globe Newswire
October 29, 2020
9:00 am ET
Globe Newswire
October 27, 2020
9:36 am ET
Globe Newswire
October 26, 2020
9:01 am ET
Globe Newswire
October 15, 2020
4:05 pm ET
Globe Newswire
9:12 am ET
MarketWatch
October 08, 2020
9:00 am ET
Globe Newswire
October 05, 2020
9:09 am ET
Globe Newswire
September 29, 2020
4:05 pm ET
Globe Newswire
September 10, 2020
4:07 pm ET
Globe Newswire
September 03, 2020
8:45 am ET
Globe Newswire
August 28, 2020
4:05 pm ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.